2 completed, 1 active not recruiting, 1 not yet recruiting, 1 recruiting. 3 Phase 2, 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Completed 1, Not yet recruiting 1 |
| Not applicable | 2 | Completed 1, Recruiting 1 |
Follow Burkitt Leukemia: new trials by email Literature Review of Burkitt Leukemia trials Research Report on Burkitt Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome Allogeneic CD34+-enriched and CD45RA-depleted PBSCs, Biospecimen Collection, Bone Marrow Aspiration - Acute Biphenotypic Leukemia, Acute Leukemia | Phase 2 | Not yet recruiting | Fred Hutchinson Cancer Center | 52 | 2027-01-01 | 2026-09-14 |
| MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi) - Leukemia, Acute Myeloid Leukemia in Remission | Not applicable | Recruiting | Medical College of Wisconsin | 40 | 2023-05-01 | 2026-05-13 |
| Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant Total-Body Irradiation, Thiotepa, Fludarabine - Acute Biphenotypic Leukemia, Acute Leukemia | Phase 2 | Active not recruiting | Fred Hutchinson Cancer Center | 45 | 2019-08-29 | 2026-09-25 |
| Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma Laboratory Biomarker Analysis, Quality-of-Life Assessment, Questionnaire Administration - Adult Nasal Type Extranodal NK/T-Cell Lymphoma, Adult T-Cell Leukemia/Lymphoma | Not applicable | Completed | Mayo Clinic | 29 | 2016-01-19 | 2019-11-15 |
| Combination Chemotherapy and Ofatumumab in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Cyclophosphamide, Cytarabine, Dexamethasone - Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic Leukemia in Complete Remission | Phase 2 | Completed | M.D. Anderson Cancer Center | 72 | 2011-07-12 | 2021-05-03 |
Burkitt Lymphoma (5) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (4) · Blastic Plasmacytoid Dendritic Cell Neoplasm (3) · Leukemia, Biphenotypic, Acute (3) · Leukemia, Mast-Cell (2) · Anemia, Refractory, with Excess of Blasts (1) · Enteropathy-Associated T-Cell Lymphoma (1) · GATA2 Deficiency (1) · Immunoblastic Lymphadenopathy (1) · Leukemia (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid (1) · Leukemia, Myeloid, Accelerated Phase (1) · Leukemia, Myeloid, Acute (1)
DNA Virus Infections (5) · Epstein-Barr Virus Infections (5) · Hematologic Diseases (5) · Hemic and Lymphatic Diseases (5) · Herpesviridae Infections (5) · Immune System Diseases (5) · Immunoproliferative Disorders (5) · Infections (5) · Leukemia, Lymphoid (5) · Lymphatic Diseases (5) · Lymphoma, B-Cell (5) · Lymphoma, Non-Hodgkin (5) · Lymphoproliferative Disorders (5) · Neoplasms (5) · Neoplasms by Histologic Type (5)
Cyclophosphamide (3) · Methotrexate (2) · Whole-Body Irradiation (2) · fludarabine (2) · Biopsy (1) · Bone Marrow Transplantation (1) · Busulfan (1) · Calcium Dobesilate (1) · Cytarabine (1) · Dexamethasone (1) · Doxorubicin (1) · Salvia hispanica seed extract (1) · Specimen Handling (1) · Tacrolimus (1) · Thiotepa (1)
Fred Hutchinson Cancer Center (2) · M.D. Anderson Cancer Center (1) · Mayo Clinic (1) · Medical College of Wisconsin (1)
United States (5)
Elias Jabbour (1) · Marie Bleakley (1) · Phuong Vo, MD (1) · Thomas Witzig (1)
PMID 32589978, PMID 33049057, PMID 34138471, PMID 35622074
P01CA018029 (1), P30CA015083 (1), P30CA015704 (1)